Cardiac Rhythm Management

banner Zoll 2018 Webcast vest

 

Activity Description

This educational activity evaluates the efficacy of the Wearable Cardioverter-Defibrillator through an in-depth analysis of the VEST trial; including an interpretation of outcomes data, and an assessment of the clinical implications on daily practice based upon the results.

Cardiac Rhythm Management

Access Presentation

Webcast

Click on each chapter title listed below to view discussion on that topic.

For those wishing to obtain your continuing medical education certification, access Earn CME Credit Tab at the conclusion of the webcast; select the appropriate answer to each posttest question, and successfully obtain the passing score as designated at the top of the test.

 

Cardiac Rhythm Management

Faculty

tmb zoll 2018 vest trial D Bhatt port

Deepak Bhatt, MD, MPH
Professor at Harvard
Executive Director of Interventional Cardiovascular Programs
Brigham and Women's Hospital
Boston, MA

tmb zoll 2018 vest trial J Olgin port

Jeffrey Olgin, MD
Co-Director of the Heart and Vascular Center
Chief of Cardiology
University of California, San Francisco
San Francisco, CA

Cardiac Rhythm Management

 

Commercial Supporter

This activity is supported by an educational grant from ZOLL

Joint-Providers

MediaSphere Medical, LLC and Ciné-Med

 

 

CME Information

CME Released: 9/26/2018; Valid for credit through 9/26/2019

Target Audience

This activity has been developed to meet the educational needs of electrophysiologists, cardiologists, and other physicians and associated healthcare professionals.

Activity Goal

This activity is designed to address the following ABMS/IOM competencies: Patient Care, Medical Knowledge, and Practice-Based Learning.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Review the rationale and design of the VEST clinical trial.
  • Evaluate VEST clinical trial outcomes data.
  • Assess what the results of the VEST trial mean for daily clinical practice.

Accreditation Statement

Jointly Accredited Provider TMIn support of improving patient care, this activity has been planned and implemented by Cine-Med and MediaSphere Medical. Cine-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Ciné-Med designates this enduring activity for a maximum of 1 AMA PRA Category 1Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity provides 1 contact hours for nurses.

Disclosure

MediaSphere Medical and Ciné-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty's commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. All Ciné-Med and MediaSphere Medical employees and planners in control of content have indicated that they have no relevant financial relationships to disclose.

Faculty Disclosure Summary

Dr. Deepak Bhatt has no personal disclosures.
Dr. Jeffrey Olgin
has no personal disclosures.

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. This activity is designed to be completed within the time designated on the title page; physicians and nurses should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™ or Contact Hours, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. Review the educational presentations
  3. Select the appropriate answer to each posttest question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

Provider Contact Information

For technical support or CME/CE questions regarding this activity, please email us at cme@mediaspheremed.com.

Hardware/Software Requirements:

  • A computer with an Internet connection.
  • Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser.
  • Adobe Flash Player and/or an HTML5 capable browser may be required for video or audio playback.
  • Occasionally other additional software may be required such as PowerPoint or Adobe Acrobat Reader.

MediaSphere protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MediaSphere and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. MediaSphere maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2018 by MediaSphere Medical. All rights reserved. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from MediaSphere Medical

Non Endorsement Statement

MediaSphere Medical and Ciné-Med verifies that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process.  MediaSphere Medical and Ciné-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.

 

CME/CE Test

CME/CE Test
  1. Evaluating the Efficacy of the Wearable Cardioverter-Defibrillator: What Do the Results of the VEST Trial Mean for Clinical Practice?
  2. Please enter your information, and complete the following CME post test and evaluation form. Upon successful completion, your submission will be reviewed and you will receive notification shortly regarding the status of your certificate. You must achieve a minimum score of 70% to earn credit for this activity.

  3. First Name: *  
    Invalid Input
  4. Last Name: *  
    Invalid Input
  5. Primary Email Address: *  
    Invalid Input
  6. Confirm Your Email: *  
    Invalid Input
  7. Credential: *  
    Invalid Input
  8. Specialty:*  
    Invalid Input
  9. Institution: *  
    Invalid Input
  10. Mailing Address:*  
    Invalid Input
  11. City: *  
    Invalid Input
  12. State: *  
    Invalid Input

  13. 1.The background behind why the VEST Trial was conducted is due to the increased risk of SCD early post MI, which is heighted in patients with a low ejection fraction after MI.
  14. Select one*  


    Invalid Input Please Select one

  15. 2. The results of the DINAMIT and IRIS study both concluded that there is no long-term mortality benefit from early ICD implantation in the post MI patient population.
  16. Select one*  


    Invalid Input Please Select one

  17. 3. Current guidelines for the Primary Prevention of SCD in Patients with Ischemic Heart Disease recommend that patients with LVEF of 35% or less that is due to ischemic heart disease who are at least 40 days post-MI, and at least 90 days post revascularization, and with NYHA class II or III HF despite GDMT, an ICD is recommended if meaningful survival of greater than 1 year is expected.
  18. Select one*  


    Invalid Input Please Select one

  19. 4. Which statement is accurate surrounding the rationale of the VEST Trial which evaluates if a Wearable Cardioverter-Defibrillator (WCD) can reduce SD mortality in the immediate post MI period (<90 days) in patients with reduced LVEF, as a bridge to evaluation for ICD?
  20. Select one*  





    Invalid Input Please Select one

  21. 5. Which statement is accurate surrounding the VEST data as it pertains to sudden death vs total mortality as interpreted by Dr. Jeffrey Olgin, the Co-Principal Investigator of the VEST Trial?
  22. Select one*  







    Invalid Input Please Select one

  23. 6. Which VEST Clinical Trial conclusion statement is accurate?
  24. Select one*  






    Invalid Input Please Select one

  25. Although optional, we respectfully request that you complete the activity evaluation form, since your feedback assists in the development of future educational activities.

  26. Background

    Please rate each question using a scale of 1 to 5 (1 = Beginner, 5 = Advanced)


  27. I would consider my level of expertise in the subject matter prior to the webcast as:
    Invalid Input Please Select one

  28. I would consider my level of expertise in the subject matter after the activity
    Invalid Input

  29. Considering my experience and background, the material presented was:
    Invalid Input Please Select one

  30. Extent to which activity met the identified objectives
    Please rate each question using a scale of 1 to 5 (1 = Not Met, 5 = Completely Met)

  31. Review the rationale and design of the VEST clinical trial.
    Invalid Input Please Select one

  32. Evaluate VEST clinical trial outcomes data.
    Invalid Input Please Select one

  33. Assess what the results of the VEST trial mean for daily clinical practice.
    Invalid Input Please Select one

  34. Examine the post epicardial ablation voltage map as a guide for endocardial ablation targets.
    Invalid Input

  35. Information Presented
    Please evaluate the information that was presented by answering Yes, No, Maybe or Not Applicable

  36. Reinforced my current practice/treatment habits:
    Invalid Input Please Select one

  37. Will improve my practice/patient outcomes:
    Invalid Input Please Select one

  38. Enhanced my current knowledge base:
    Invalid Input Please Select one

  39. Provided new ideas or information that I expect to use:
    Invalid Input Please Select one

  40. Information gained from this conference will result in making a change in your practice:
    Invalid Input Please Select one

  41. Future activities on this subject matter is important to my practice:
    Invalid Input Please Select one

  42. Addressed a professional practice gap:
    Invalid Input Please Select one

  43. Was free of commercial bias/influence:
    Invalid Input Please Select one

  44. What barriers do you anticipate in incorporating best practices learned in this activity into clinical activities or quality improvement initiatives at your institution?
    Invalid Input

  45. What mechanisms can you identify to overcome these barriers?
    Invalid Input

  46. (*) Required Fields
  47. Invalid Input

Cardiac Rhythm Management